EIT Health Innovation Validation 2027: up to €850,000 for digital medical devices

On 14 October 2026, EIT Health opened the Innovation Validation Call 2027, for consortia led by a company that markets a digital or artificial intelligence-based medical device. Grants cover at most 50% of the project budget, up to €850,000 per project. Applications must be submitted by 13 January 2027, 16:00 CET.

In brief

• Programme: EIT Health – Innovation Validation Call 2027
• Authority: EIT Health, within the European Institute of Innovation and Technology (EIT)
• Beneficiaries: consortia of at least two organisations from different countries, led by a company that markets the solution
• Value per project / intensity: maximum 50% of the budget, up to €850,000 per project; if the lead company marketing the solution is a micro-enterprise or small enterprise, it must receive between €400,000 and €500,000 of the grant
• Submission period: 14 October 2026 – 13 January 2027, 16:00 CET
• Status: call open

Who can apply?

The application must be submitted by a consortium of at least two organisations from different countries, representing at least two sides of the knowledge triangle (industry, research, education). The project is led by a company that markets the solution.

The solution must be a digital or AI-based medical device, regulated under the MDR/IVDR, at innovation maturity level (IML) 6. The aim is to reach IML 7 by the end of the project. The official page mentions no specific restrictions for Romania; however, check the full rules in the call documents.

What activities are funded?

According to the official page, the call funds activities that enable clinical validation (pivotal clinical studies), submission of the regulatory file (the CE marking dossier), finalisation of the product, market readiness and commercial strategy.

The expected results are an impact on more than 150,000 patients or EU citizens and revenues of at least €10,000 in the three years after funding.

How and by when do you apply?

1. Each organisation registers its entity in the EU Funding & Tenders portal and obtains a PIC code.
2. The application is submitted through the EIT Health application platform.
3. The deadline is 13 January 2027, 16:00 CET.

Supporting documents (guide, forms) are provided by EIT Health through a secure sharing link, indicated on the official page.

What this means for your business

Recommendation: the call suits companies that already have a validated prototype-level product and need money for the expensive stage: the clinical study and CE certification. If the solution is still at idea stage, a call for lower maturity is more realistic.

• Start looking for partners in other countries now; forming an international consortium takes the longest.
• Check whether your product qualifies as a medical device under the MDR/IVDR and what its class is.
• Bear in mind that the grant covers only 50% of the budget, so the remaining co-financing must be secured from your own or private sources.
• Obtain the PIC code for all partners in good time.

You can carry out a preliminary check with the eligibility check.

Frequently asked questions

Can a Romanian company apply on its own?

No. The consortium must include at least two organisations from different countries, and the company that markets the solution leads the project.

How much does a small start-up receive?

If the lead company marketing the solution is a micro-enterprise or small enterprise, it must receive between €400,000 and €500,000 of the grant, within the maximum of 50% of the project budget and €850,000 per project.

What types of products are eligible?

Digital or AI-based medical devices (MDR/IVDR), at IML 6 maturity level.

What is the deadline?

13 January 2027, 16:00 CET.

Official sources

• EIT – Innovation Validation Call 2027

Information checked on 2 November 2026. The conditions may be amended by the managing authority — check the guide in force before submitting.